Lv1
34 积分 2023-07-28 加入
Real-world safety and effectiveness of pirfenidone and nintedanib in the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis
5天前
已完结
Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis
27天前
已完结
Idiopathic pulmonary fibrosis: Diagnosis, biomarkers and newer treatment protocols
27天前
已完结
Advances in Targeted Therapy for Progressive Fibrosing Interstitial Lung Disease
27天前
已完结
Practical guidance for the early recognition and follow-up of patients with connective tissue disease-related interstitial lung disease
28天前
已完结
Efficacy and safety of antifibrotic agents in the treatment of CTD-ILD and RA-ILD: A systematic review and meta-analysis
28天前
已完结
Management of connective tissue diseases associated interstitial lung disease
28天前
已完结
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study
28天前
已完结
Severe adverse events impact overall survival and costs in elderly patients with advanced non-small cell lung cancer on second-line therapy
2个月前
已完结
The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide
2个月前
已完结
皖公网安备34019202002308
